Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis.
Benedetti S, Previtali SC, Coviello S, Scarlato M, Cerri F, Di Pierri E, Piantoni L, Spiga I, Fazio R, Riva N, Natali Sora MG, Dacci P, Malaguti MC, Munerati E, Grimaldi LM, Marrosu MG, De Pellegrin M, Ferrari M, Comi G, Quattrini A, Bolino A. Benedetti S, et al. Among authors: grimaldi lm. Arch Neurol. 2010 Dec;67(12):1498-505. doi: 10.1001/archneurol.2010.303. Arch Neurol. 2010. PMID: 21149811
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group. Comi G, et al. J Neurol. 2017 Dec;264(12):2436-2449. doi: 10.1007/s00415-017-8642-5. Epub 2017 Oct 23. J Neurol. 2017. PMID: 29063244 Free PMC article. Clinical Trial.
Multicenter Interventional Phase IV Study for the Assessment of the Effects on Patient's Satisfaction of Peg IFN Beta-1a (Pre-filled Pen) in Subjects With Relapsing-Remitting Multiple Sclerosis Unsatisfied With Other Injectable Subcutaneous Interferons (PLATINUM Study).
Centonze D, Fantozzi R, Buttari F, Grimaldi LME, Totaro R, Corea F, Marrosu MG, Confalonieri P, Cottone S, Trojano M, Zipoli V. Centonze D, et al. Front Neurol. 2021 Apr 22;12:637615. doi: 10.3389/fneur.2021.637615. eCollection 2021. Front Neurol. 2021. PMID: 33967938 Free PMC article.
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.
Bucello S, Annovazzi P, Ragonese P, Altieri M, Barcella V, Bergamaschi R, Bianchi A, Borriello G, Buscarinu MC, Callari G, Capobianco M, Capone F, Cavalla P, Cavarretta R, Cortese A, De Luca G, Di Filippo M, Dattola V, Fantozzi R, Ferraro E, Filippi MM, Gasperini C, Grimaldi LME, Landi D, Re ML, Mallucci G, Manganotti P, Marfia GA, Mirabella M, Perini P, Pisa M, Realmuto S, Russo M, Tomassini V, Torri-Clerici VLA, Zaffaroni M, Zuliani C, Zywicki S, Filippi M, Prosperini L. Bucello S, et al. J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22. J Neurol. 2021. PMID: 33616742
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.
Filippi M, Grimaldi L, Conte A, Totaro R, Valente MR, Malucchi S, Granella F, Cordioli C, Brescia Morra V, Zanetta C, Perini D, Santoni L; EASIER Study Working Group. Filippi M, et al. J Neurol. 2024 Jan;271(1):340-354. doi: 10.1007/s00415-023-11955-0. Epub 2023 Sep 16. J Neurol. 2024. PMID: 37715789 Free PMC article.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Sorosina M, Brambilla P, Clarelli F, Barizzone N, Lupoli S, Guaschino C, Osiceanu AM, Moiola L, Ghezzi A, Coniglio G, Patti F, Mancardi G, Manunta P, Glorioso N, Guerini FR, Bergamaschi R, Perla F; PROGRESSO; PROGEMUS; Martinelli V, Cusi D, Leone M, Comi G, D'Alfonso S, Martinelli-Boneschi F. Sorosina M, et al. Mult Scler. 2014 Jun;20(7):802-11. doi: 10.1177/1352458513512707. Epub 2013 Nov 25. Mult Scler. 2014. PMID: 24277324
Natalizumab in the pediatric MS population: results of the Italian registry.
Ghezzi A, Moiola L, Pozzilli C, Brescia-Morra V, Gallo P, Grimaldi LM, Filippi M, G GC; MS Study Group-Italian Society of Neurology. Ghezzi A, et al. Among authors: grimaldi lm. BMC Neurol. 2015 Sep 25;15:174. doi: 10.1186/s12883-015-0433-y. BMC Neurol. 2015. PMID: 26407848 Free PMC article.
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis.
D'Amico E, Zanghì A, Sciandra M, Lanzillo R, Callari G, Cortese A, Lus G, Lucchini M, Buccafusca M, Bonavita S, Gallo A, Curti E, Gajofatto A, Signoriello E, Bisecco A, Gobbin F, Ferrò MT, Ferrazzano G, Sparaco M, Valentino P, Mirabella M, Granella F, Bresciamorra V, Grimaldi LME, Patti F; ITALIAN-DIME-TERI group. D'Amico E, et al. J Neurol. 2020 Oct;267(10):3008-3020. doi: 10.1007/s00415-020-09959-1. Epub 2020 Jun 6. J Neurol. 2020. PMID: 32506391
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience.
D'Amico E, Zanghì A, Callari G, Borriello G, Gallo A, Graziano G, Valentino P, Buccafusca M, Cottone S, Salemi G, Ragonese P, Bossio RB, Docimo R, Grimaldi LME, Pozzilli C, Tedeschi G, Zappia M, Patti F. D'Amico E, et al. Ther Adv Neurol Disord. 2018 Sep 10;11:1756286418796404. doi: 10.1177/1756286418796404. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 30210582 Free PMC article.
182 results